{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:18:20Z","timestamp":1784971100829,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901270"],"award-info":[{"award-number":["81901270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072229"],"award-info":[{"award-number":["82072229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.intimp.2021.107919","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T01:39:28Z","timestamp":1625103568000},"page":"107919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Global research trends of Apolipoprotein E in central nervous system: A scientometric analysis"],"prefix":"10.1016","volume":"98","author":[{"given":"Kai","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2021.107919_b0005","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00415-018-8818-7","article-title":"Stem cells in the treatment of central nervous system disease","volume":"265","author":"McLauchlan","year":"2018","journal-title":"J Neurol."},{"key":"10.1016\/j.intimp.2021.107919_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113094","article-title":"MicroRNAs in central nervous system diseases: A prospective role in regulating blood-brain barrier integrity","volume":"323","author":"Ma","year":"2020","journal-title":"Exp Neurol."},{"issue":"120","key":"10.1016\/j.intimp.2021.107919_b0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2016.03.021","article-title":"The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes","volume":"1","author":"Gribkoff","year":"2017","journal-title":"Neuropharmacology."},{"issue":"7","key":"10.1016\/j.intimp.2021.107919_b0020","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107919_b0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr Opin Lipidol."},{"issue":"8","key":"10.1016\/j.intimp.2021.107919_b0030","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J Lipid Res."},{"key":"10.1016\/j.intimp.2021.107919_b0035","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1146\/annurev.biochem.78.072407.103859","article-title":"Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain","volume":"78","author":"Russell","year":"2009","journal-title":"Annu Rev Biochem."},{"issue":"8","key":"10.1016\/j.intimp.2021.107919_b0040","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbalip.2010.02.007","article-title":"Formation and function of apolipoprotein E-containing lipoproteins in the nervous system","volume":"1801","author":"Vance","year":"2010","journal-title":"Biochim Biophys Acta."},{"issue":"15","key":"10.1016\/j.intimp.2021.107919_b0045","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1007\/s00018-004-4009-z","article-title":"The role of apolipoprotein E in lipid metabolism in the central nervous system","volume":"61","author":"Han","year":"2004","journal-title":"Cell Mol Life Sci."},{"issue":"8","key":"10.1016\/j.intimp.2021.107919_b0050","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem Sci."},{"issue":"6376","key":"10.1016\/j.intimp.2021.107919_b0055","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1126\/science.aan4183","article-title":"Defective cholesterol clearance limits remyelination in the aged central nervous system","volume":"359","author":"Cantuti-Castelvetri","year":"2018","journal-title":"Science."},{"issue":"10","key":"10.1016\/j.intimp.2021.107919_b0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","article-title":"Cholesterol metabolism in Huntington disease","volume":"7","author":"Karasinska","year":"2011","journal-title":"Nat Rev Neurol."},{"issue":"17","key":"10.1016\/j.intimp.2021.107919_b0065","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/cmdc.201800452","article-title":"Cholesterol: A Key in the Pathogenesis of Alzheimer's Disease","volume":"13","author":"Banerjee","year":"2018","journal-title":"ChemMedChem."},{"issue":"3","key":"10.1016\/j.intimp.2021.107919_b0070","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mds.27609","article-title":"Brain cholesterol metabolism and Parkinson's disease","volume":"34","author":"Huang","year":"2019","journal-title":"Mov Disord."},{"key":"10.1016\/j.intimp.2021.107919_b0075","article-title":"Serum Levels of HDL Cholesterol are Associated with Diffuse Axonal Injury in Patients with Traumatic Brain Injury","author":"Zhong","year":"2020","journal-title":"Neurocrit Care."},{"key":"10.1016\/j.intimp.2021.107919_b0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: Pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2021.107919_b0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/ijms20010081","article-title":"The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives","volume":"20","author":"Wolfe","year":"2018","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.intimp.2021.107919_b0090","doi-asserted-by":"crossref","unstructured":"Huang Y, Mahley RW. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol Dis. 2014 Dec;72 Pt A:3-12.","DOI":"10.1016\/j.nbd.2014.08.025"},{"issue":"6","key":"10.1016\/j.intimp.2021.107919_b0095","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell."},{"key":"10.1016\/j.intimp.2021.107919_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0404.2006.00680.x","article-title":"Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease","volume":"185","author":"Laskowitz","year":"2006","journal-title":"Acta Neurol Scand Suppl."},{"issue":"19","key":"10.1016\/j.intimp.2021.107919_b0105","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Qin","year":"2006","journal-title":"J Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2021.107919_b0110","first-page":"183","article-title":"Influence of apolipoprotein E and its receptors on cerebral amyloid precursor protein metabolism following traumatic brain injury","volume":"15","author":"Zhou","year":"2012","journal-title":"Chin J Traumatol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107919_b0115","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2015.8.FOCUS15329","article-title":"Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review","volume":"39","author":"Maiti","year":"2015","journal-title":"Neurosurg Focus."},{"issue":"4","key":"10.1016\/j.intimp.2021.107919_b0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","article-title":"Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease","volume":"83","author":"Zhao","year":"2018","journal-title":"Biol Psychiatry."},{"issue":"8","key":"10.1016\/j.intimp.2021.107919_b0125","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1194\/jlr.R075408","article-title":"The role of APOE on lipid homeostasis and inflammation in normal brains","volume":"58","author":"Rebeck","year":"2017","journal-title":"J Lipid Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.107919_b0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13311-020-00858-x","article-title":"Therapeutic Development of Apolipoprotein E Mimetics for Acute Brain Injury: Augmenting Endogenous Responses to Reduce Secondary Injury","volume":"17","author":"James","year":"2020","journal-title":"Neurotherapeutics."},{"issue":"4852","key":"10.1016\/j.intimp.2021.107919_b0135","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.intimp.2021.107919_b0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pathol.2018.11.002","article-title":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease","volume":"51","author":"Marais","year":"2019","journal-title":"Pathology."},{"issue":"4","key":"10.1016\/j.intimp.2021.107919_b0145","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/MOL.0000000000000615","article-title":"The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease","volume":"30","author":"Valanti","year":"2019","journal-title":"Curr Opin Lipidol."},{"key":"10.1016\/j.intimp.2021.107919_b0150","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.archoralbio.2018.11.009","article-title":"31. Ori\u00e1 RB. Apolipoprotein E, periodontal disease and the risk for atherosclerosis: a review","volume":"98","author":"Pereira","year":"2019","journal-title":"Arch Oral Biol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107919_b0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.kint.2019.10.031","article-title":"Apolipoprotein E-related glomerular disorders","volume":"97","author":"Saito","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2021.107919_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2019.07.011","article-title":"Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review","author":"Nascimento","year":"2020","journal-title":"Ann Hepatol."},{"issue":"20","key":"10.1016\/j.intimp.2021.107919_b0165","first-page":"30135","article-title":"Apolipoprotein E Effects on Mammalian Ovarian Steroidogenesis and Human Fertility","volume":"S1043\u20132760","author":"Ori\u00e1","year":"2020","journal-title":"Trends Endocrinol Metab."},{"issue":"12","key":"10.1016\/j.intimp.2021.107919_b0170","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/jnnp.2006.097543","article-title":"Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage","volume":"77","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"2","key":"10.1016\/j.intimp.2021.107919_b0175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ije\/dyt034","article-title":"Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals","volume":"42","author":"Khan","year":"2013","journal-title":"Int J Epidemiol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107919_b0180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology."},{"issue":"6","key":"10.1016\/j.intimp.2021.107919_b0185","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.23571","article-title":"Neuroinflammation in the central nervous system: Symphony of glial cells","volume":"67","author":"Yang","year":"2019","journal-title":"Glia."},{"issue":"9","key":"10.1016\/j.intimp.2021.107919_b0190","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","article-title":"APOE genotype-specific differences in the innate immune response","volume":"30","author":"Vitek","year":"2009","journal-title":"Neurobiol Aging."},{"issue":"4","key":"10.1016\/j.intimp.2021.107919_b0195","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/glia.22289","article-title":"APOE genotype alters glial activation and loss of synaptic markers in mice","volume":"60","author":"Zhu","year":"2012","journal-title":"Glia."},{"issue":"11","key":"10.1016\/j.intimp.2021.107919_b0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1742-2094-11-111","article-title":"Human APOE4 increases microglia reactivity at A\u03b2 plaques in a mouse model of A\u03b2 deposition","volume":"19","author":"Rodriguez","year":"2014","journal-title":"J Neuroinflammation."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2021.107919_b0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2014.03.010","article-title":"Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis","volume":"271","author":"Shin","year":"2014","journal-title":"J Neuroimmunol."},{"issue":"2019","key":"10.1016\/j.intimp.2021.107919_b0210","first-page":"3832648","article-title":"Apolipoprotein E Deficiency Aggravates Neuronal Injury by Enhancing Neuroinflammation via the JNK\/c-Jun Pathway in the Early Phase of Experimental Subarachnoid Hemorrhage in Mice","volume":"26","author":"Wu","year":"2019","journal-title":"Oxid Med Cell Longev."},{"issue":"1","key":"10.1016\/j.intimp.2021.107919_b0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/jcbfm.2010.99","article-title":"Age-dependent effect of apolipoprotein E4 on functional outcome after controlled cortical impact in mice","volume":"31","author":"Mannix","year":"2011","journal-title":"J Cereb Blood Flow Metab."},{"issue":"49","key":"10.1016\/j.intimp.2021.107919_b0220","doi-asserted-by":"crossref","first-page":"48529","DOI":"10.1074\/jbc.M306923200","article-title":"APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response","volume":"278","author":"Lynch","year":"2003","journal-title":"J Biol Chem."},{"issue":"4","key":"10.1016\/j.intimp.2021.107919_b0225","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/svn-2018-000152","article-title":"Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH","volume":"3","author":"Liu","year":"2018","journal-title":"Stroke Vasc Neurol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107919_b0230","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2011.05.050","article-title":"Apolipoprotein E isoform-specific effects on cytokine and nitric oxide production from mouse Schwann cells after inflammatory stimulation","volume":"499","author":"Zhang","year":"2011","journal-title":"Neurosci Lett."},{"issue":"1","key":"10.1016\/j.intimp.2021.107919_b0235","first-page":"737","article-title":"Apolipoprotein E knockout induced inflammatory responses related to microglia in neonatal mice brain via astrocytes","volume":"8","author":"Liu","year":"2015","journal-title":"Int J Clin Exp Med."},{"issue":"5","key":"10.1016\/j.intimp.2021.107919_b0240","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/ATVBAHA.111.222745","article-title":"Apolipoprotein E induces antiinflammatory phenotype in macrophages","volume":"31","author":"Baitsch","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107919_b0245","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1046\/j.1471-4159.2003.01788.x","article-title":"Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide","volume":"85","author":"Saura","year":"2003","journal-title":"J Neurochem."},{"issue":"3","key":"10.1016\/j.intimp.2021.107919_b0250","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.bbrc.2009.07.048","article-title":"Inhibition of c-Jun N-terminal kinase increases apoE expression in vitro and in vivo","volume":"387","author":"Pocivavsek","year":"2009","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"10.1016\/j.intimp.2021.107919_b0255","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/glia.20772","article-title":"Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase","volume":"57","author":"Pocivavsek","year":"2009","journal-title":"Glia."},{"issue":"3","key":"10.1016\/j.intimp.2021.107919_b0260","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","article-title":"ApoE attenuates unresolvable inflammation by complex formation with activated C1q","volume":"25","author":"Yin","year":"2019","journal-title":"Nat Med."},{"issue":"1","key":"10.1016\/j.intimp.2021.107919_b0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tins.2019.11.005","article-title":"Fiery Cell Death: Pyroptosis in the Central Nervous System","volume":"43","author":"McKenzie","year":"2020","journal-title":"Trends Neurosci."},{"issue":"10","key":"10.1016\/j.intimp.2021.107919_b0270","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat Rev Neurosci."},{"issue":"11","key":"10.1016\/j.intimp.2021.107919_b0275","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fnmol.2018.00320","article-title":"Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases","volume":"4","author":"Shao","year":"2018","journal-title":"Front Mol Neurosci."},{"issue":"6","key":"10.1016\/j.intimp.2021.107919_b0280","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810248","article-title":"Inflammasomes in neuroinflammatory and neurodegenerative diseases","volume":"11","author":"Voet","year":"2019","journal-title":"EMBO Mol Med."},{"issue":"8","key":"10.1016\/j.intimp.2021.107919_b0285","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/ATVBAHA.117.309575","article-title":"NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report","volume":"37","author":"van der Heijden","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"174","key":"10.1016\/j.intimp.2021.107919_b0290","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ecoenv.2019.02.064","article-title":"Fine particulate matter-induced cardiovascular injury is associated with NLRP3 inflammasome activation in Apo E(-\/-) mice","volume":"15","author":"Du","year":"2019","journal-title":"Ecotoxicol Environ Saf."},{"key":"10.1016\/j.intimp.2021.107919_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105934","article-title":"C1q\/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway","volume":"77","author":"Zhang","year":"2019","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107919_b0300","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12964-019-0406-7","article-title":"NFAT5 mediates hypertonic stress-induced atherosclerosis via activating NLRP3 inflammasome in endothelium","volume":"17","author":"Ma","year":"2019","journal-title":"Cell Commun Signal."},{"issue":"12","key":"10.1016\/j.intimp.2021.107919_b0305","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1002\/jcp.29813","article-title":"Interleukin-36 receptor antagonist attenuates atherosclerosis development by inhibiting NLRP3 inflammasome","volume":"235","author":"Tian","year":"2020","journal-title":"J Cell Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107919_b0310","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2019.02.027","article-title":"Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1\u03b2 secretion by bronchoalveolar fluid macrophages from asthmatic subjects","volume":"144","author":"Gordon","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.intimp.2021.107919_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106301","article-title":"Apolipoprotein E negatively regulates murine allergic airway inflammation via suppressing the activation of NLRP3 inflammasome and oxidative stress","volume":"81","author":"Zhao","year":"2020","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107919_b0320","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12974-020-01869-3","article-title":"25-Hydroxycholesterol amplifies microglial IL-1\u03b2 production in an apoE isoform-dependent manner","volume":"17","author":"Wong","year":"2020","journal-title":"J Neuroinflammation."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:26:38Z","timestamp":1747308398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921005555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":64,"alternative-id":["S1567576921005555"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107919","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global research trends of Apolipoprotein E in central nervous system: A scientometric analysis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107919"}}